Filing Details
- Accession Number:
- 0001209191-21-018528
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-08 16:10:30
- Reporting Period:
- 2021-03-05
- Accepted Time:
- 2021-03-08 16:10:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1847529 | Joy Liu | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Svp, General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-03-05 | 1,351 | $207.57 | 12,043 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-05 | 1,119 | $208.39 | 10,924 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-05 | 111 | $209.37 | 10,813 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-05 | 844 | $210.64 | 9,969 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-05 | 1,460 | $211.67 | 8,509 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-05 | 256 | $212.28 | 8,253 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Ms. Liu's company-approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $207.57 (range $206.93 to $207.92).
- Ms. Liu undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $208.39 (range $207.93 to $208.67).
- Open market sales reported on this line occurred at a weighted average price of $209.37 (range $208.98 to $209.64).
- Open market sales reported on this line occurred at a weighted average price of $210.64 (range $210.00 to $210.97).
- Open market sales reported on this line occurred at a weighted average price of $211.67 (range $211.08 to $212.07).
- Open market sales reported on this line occurred at a weighted average price of $212.28 (range $212.08 to $212.45).
Billionaire Hedge Funds
